女性医療診断の世界市場予測（～2021）：出生前検査、ダウン症候群検査、HPV検査、受胎能試験、妊娠テスト、 尿路感染症検査、骨粗鬆症検査、乳がん検査、子宮頸がん検査、卵巣がん検査...市場調査レポートについてご紹介

1 Introduction (Page No. – 22)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 26)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 34)

4 Premium Insights (Page No. – 37)
4.1 Women’s Health Diagnostics: Market Overview
4.2 Asia-Pacific: Pregnancy and Fertility Testing Market, By Product Type (2015)
4.3 Geographic Snapshot of the Women’s Health Diagnostics Market
4.4 Geograpgic Mix: Women’s Health Diagnostics Market
4.5 Women’s Health Diagnostics Market: Developed vs Developing Markets

5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 High Prevalence of Infectious Diseases in Women
5.2.1.2 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women
5.2.1.3 Increasing Awareness About Fertility Testing in Women and IniTIAtives Taken By Government and Health Organizations
5.2.1.4 Increased Adoption of Point-Of-Care and Rapid Diagnostic Tests
5.2.1.5 Growth in the Number of Private Diagnostic and Imaging Centers
5.2.1.6 Public-Private Partnerships to Enhance the Infrastructure of Diagnostic Imaging Centers
5.2.2 Key Market Restraints
5.2.2.1 High Cost of Diagnostic Imaging Systems and Procedures
5.2.2.2 Shortage of Skilled Laboratory Technicians
5.2.3 Key Market Opportunities
5.2.3.1 Improving Healthcare Infrastructure in Emerging Markets
5.2.3.2 Growing Number of Regulatory Approvals for Immunoassay Diagnostic Techniques
5.2.4 Key Market Challenges
5.2.4.1 Stringent Regulatory Guidelines
5.2.4.2 Increasing Adoption of Refurbished Diagnostic Imaging Systems

6 Industry Insights (Page No. – 53)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Focus on Microfluidics- and Nanotechnology-Based POC Devices for Diagnostics
6.2.1.1 Microfluidics-Based Lab-On-A-Chip (LoC) Devices for Laboratory Testing
6.2.1.2 Evolution of Paper-Based Microfluidic Poc Diagnostic Devices
6.2.2 Rising Focus of Market Players on Pregnancy and Fertility Issues in Emerging Regions
6.3 Clinical Trials Assessment for Breast Cancer Diagnostics

7 Women’s Health Diagnostics Market, By Application (Page No. – 58)
7.1 Introduction
7.2 Osteoporosis Testing
7.2.1 Bone Densitometry
7.2.2 in Vitro Blood Tests
7.3 Breast Cancer Testing
7.3.1 Mammography
7.3.2 Breast Cancer Tumor Marker Tests
7.3.3 Blood Chemistries and Blood Cell Count Tests
7.3.4 Biopsies
7.3.5 Other Diagnostic Imaging Tests
7.4 Ovarian Cancer Testing
7.4.1 Ovarian Cancer Tumor Marker Tests
7.4.2 Diagnostic Imaging Tests
7.4.3 Other Tests
7.5 Cervical Cancer Testing
7.5.1 PAP Smear
7.5.2 HPV Testing
7.6 Pregnancy and Fertility Testing
7.6.1 Lab-Based Testing
7.6.2 Pregnancy Testing and Ovulation Prediction Kits
7.6.3 Fertility Monitors
7.7 Prenatal Genetic Screening and Carrier Testing
7.7.1 Cystic Fibrosis
7.7.2 Down Syndrome and Edwards Syndrome
7.7.3 Torch Infections
7.7.4 Other Diseases
7.8 Infectious Disease Testing
7.8.1 MRSA Testing
7.8.2 Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
7.8.3 HEPAtitis Testing
7.8.4 Tuberculosis Testing
7.8.5 Other Infectious Diseases
7.9 Sexually Transmitted Disease Testing
7.9.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing
7.9.2 HIV Testing
7.9.3 Other Sexually Transmitted Diseases
7.10 Ultrasound Tests
7.10.1 Breast Imaging
7.10.2 OB/GYN Imaging

8 Women’s Health Diagnostics Market, By End User (Page No. – 108)
8.1 Introduction
8.2 Hospitals and Clinics
8.3 Diagnostic and Imaging Centers
8.4 Home Care

9 Women’s Health Diagnostics Market, By Region (Page No. – 115)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 RoW
9.5.1 Latin America
9.5.2 Middle East & Africa

10 Competitive Landscape (Page No. – 232)
10.1 Overview
10.2 Strategic Benchmarking
10.3 Competitive Situations and Trends
10.3.1 Product Launches
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Acquisitions
10.3.4 Regulatory Approvals

11 Company Profiles (Page No. – 241)
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Siemens AG
11.2 Quest Diagnostics Inc.
11.3 Hologic, Inc.
11.4 F. Hoffmann-La Roche AG
11.5 Perkinelmer Inc.
11.6 Alere Inc.
11.7 GE Healthcare
11.8 Becton, Dickinson and Company
11.9 Abbott Laboratories
11.10 Biomérieux SA
11.11 Koninklijke Philips N.V.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 279)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports